Insider · CIK 0001748894

GRASSO MARC

Reports to the SEC for 3 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001748894

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-13	KYTXKyverna Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2026-03-13	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2025-06-30	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	−450K sh	—	—	450,000
2025-06-02	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−16.5K sh	$1.34	−$22.1K	296,072
2025-03-03	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−18.1K sh	$1.47	−$26.5K	312,560
2024-12-02	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−16.5K sh	$2.52	−$41.5K	330,651
2024-10-01	ALECAlector, Inc.A Award	Chief Financial Officer	AAward	+216K sh	—	—	347,140
2024-09-03	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−7,297 sh	$4.88	−$35.6K	130,740
2024-06-03	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−6,920 sh	$4.80	−$33.2K	138,037
2024-03-04	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−5,716 sh	$6.92	−$39.6K	144,957
2023-12-04	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−4,574 sh	$5.56	−$25.4K	150,673
2023-10-01	ALECAlector, Inc.A Award	Chief Financial Officer	AAward	+123K sh	—	—	155,247
2023-10-01	ALECAlector, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+41K sh	—	—	41,000
2023-09-05	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−1,114 sh	$5.19	−$5,786.45	32,247
2023-06-02	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−1,050 sh	$6.90	−$7,248.885	33,361
2023-03-02	ALECAlector, Inc.S Sale	Chief Financial Officer	SSale	−1,291 sh	$8.32	−$10.7K	34,411
2022-10-01	ALECAlector, Inc.A Award	Chief Financial Officer	AAward	+35.7K sh	—	—	35,702
2022-10-01	ALECAlector, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+23.8K sh	—	—	23,801
2022-03-01	ALECAlector, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+450K sh	—	—	450,000
2022-01-26	KURAKura Oncology, Inc.A Award	CFO, CBO	AAward	+21.9K sh	—	—	21,900
2022-01-26	KURAKura Oncology, Inc. · Option to purchase common stockA Award	CFO, CBO	AAward	+131K sh	—	—	131,000
2021-01-26	KURAKura Oncology, Inc. · Option to purchase common stockA Award	CFO, CBO	AAward	+175K sh	—	—	175,000
2020-09-14	KURAKura Oncology, Inc.M Exercise/Conversion	CFO, CBO	MExercise/Conversion	+7,898 sh	$29.00	+$229K	7,898
2020-09-14	KURAKura Oncology, Inc.M Exercise/Conversion	CFO, CBO	MExercise/Conversion	+2,102 sh	$29.00	+$61K	10,000
2020-09-14	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	CFO, CBO	MExercise/Conversion	−7,898 sh	—	—	105,000
2020-09-14	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	CFO, CBO	MExercise/Conversion	−2,102 sh	—	—	247,898
2020-09-14	KURAKura Oncology, Inc.S Sale	CFO, CBO	SSale	−10K sh	$29.00	−$290K	0
2020-09-08	KURAKura Oncology, Inc.M Exercise/Conversion	CFO, CBO	MExercise/Conversion	+10K sh	$15.47	+$155K	10,000
2020-09-08	KURAKura Oncology, Inc.S Sale	CFO, CBO	SSale	−10K sh	$26.00	−$260K	0
2020-09-08	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	CFO, CBO	MExercise/Conversion	−10K sh	—	—	112,898
2020-08-25	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	CFO, CBO	MExercise/Conversion	−10K sh	—	—	122,898
2020-08-25	KURAKura Oncology, Inc.S Sale	CFO, CBO	SSale	−10K sh	$23.00	−$230K	0
2020-08-25	KURAKura Oncology, Inc.M Exercise/Conversion	CFO, CBO	MExercise/Conversion	+10K sh	$15.47	+$155K	10,000
2020-08-07	KURAKura Oncology, Inc.M Exercise/Conversion	CFO, CBO	MExercise/Conversion	+7,102 sh	$15.47	+$110K	10,000
2020-08-07	KURAKura Oncology, Inc.S Sale	CFO, CBO	SSale	−10K sh	$20.00	−$200K	0
2020-08-07	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	CFO, CBO	MExercise/Conversion	−7,102 sh	—	—	132,898
2020-01-30	KURAKura Oncology, Inc. · Option to purchase common stockA Award	CFO, CBO	AAward	+112K sh	—	—	111,723
2019-01-22	KURAKura Oncology, Inc. · Option to purchase common stockA Award	CFO, CBO	AAward	+140K sh	—	—	140,000
2018-08-21	KURAKura Oncology, Inc. · Option to purchase common stockA Award	CFO, CBO	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Mar 174
GRASSO MARC0001193125-26-110934
SEC(opens sec.gov)
Jul 14
GRASSO MARC0000950170-25-092421
SEC(opens sec.gov)
Jun 44
GRASSO MARC0001415889-25-015591
SEC(opens sec.gov)
Mar 54
GRASSO MARC0000950170-25-033539
SEC(opens sec.gov)
Dec 34
GRASSO MARC0000950170-24-132913
SEC(opens sec.gov)
Oct 24
GRASSO MARC0000950170-24-111426
SEC(opens sec.gov)
Sep 44
GRASSO MARC0000950170-24-103454
SEC(opens sec.gov)
Jun 44
GRASSO MARC0000950170-24-068937
SEC(opens sec.gov)
Mar 54
GRASSO MARC0000950170-24-026427
SEC(opens sec.gov)
Dec 64
GRASSO MARC0000950170-23-068617
SEC(opens sec.gov)
Oct 34
GRASSO MARC0000950170-23-051705
SEC(opens sec.gov)
Sep 64
GRASSO MARC0000950170-23-046831
SEC(opens sec.gov)
Jun 54
GRASSO MARC0000950170-23-026477
SEC(opens sec.gov)
Mar 34
GRASSO MARC0001209191-23-016084
SEC(opens sec.gov)
Oct 44
GRASSO MARC0001209191-22-052568
SEC(opens sec.gov)
Mar 34
GRASSO MARC0001209191-22-015410
SEC(opens sec.gov)
Jan 284
GRASSO MARC0001209191-22-005391
SEC(opens sec.gov)

Companies

Address

C/O KYVERNA THERAPEUTICS, INC. 5980 HORTON STREET, SUITE 550

EMERYVILLE, CA, 94608